|
|||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||
Press Releases See our recent press releases.
Features/Perspectives Hear and see company leadership, industry experts and patients discuss key issues and share their stories.
Media Contacts Find out who to contact if you are a member of the media.
Fact Sheets and Information Resources See additional resources for the media such as fact sheets, press kits and other information.
Corporate Overview Read a brochure about our company.
Positions / Policies Read our positions on various topics.
Baxter in the News Read recent news coverage and learn about events and recognition.
Sustainability Read our Sustainability Report and the latest news about our initiatives.
Investor Relations Read our annual report, proxy statements and other financial information.
Press Releases
Baxter Declares Quarterly Dividend
DEERFIELD, Ill., February 17, 2009 – The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.26 per share of Baxter common stock.
This payment represents a continuation of the current rate, which was increased last quarter by 20 percent. This quarterly dividend is payable on April 1, 2009, to shareholders of record as of the close of business on March 10, 2009.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
| For More Information | |
| Media Contact: Deborah Spak, (847) 948-2349 |
Investor Contacts: Mary Kay Ladone, (847) 948-3371 Clare Trachtman, (847) 948-3085 |
